This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Effects of binding partners on thermal reversion rates of photoswitchable molecules.
Proceedings of the National Academy of Sciences of the United States of America · 2025
A Non-immunogenic Bivalent d-Protein Potently Inhibits Retinal Vascularization and Tumor Growth.
ACS chemical biology · 2021
A Potent d-Protein Antagonist of VEGF-A is Nonimmunogenic, Metabolically Stable, and Longer-Circulating in Vivo.
ACS chemical biology · 2016 · first author
Latest funding
- $15,000
5th Protein Engineering Canada Conference, 2024
CIHR · 2024 · Principal investigator
4 publications.
Effects of binding partners on thermal reversion rates of photoswitchable molecules.
Reed PMM, Jang J, Woloschuk RM, Reis J, Hille JIC, Uppalapati M, Woolley GA
A Non-immunogenic Bivalent d-Protein Potently Inhibits Retinal Vascularization and Tumor Growth.
Marinec PS, Landgraf KE, Uppalapati M, Chen G, Xie D, Jiang Q, Zhao Y, Petriello A, Deshayes K, Kent SBH, Ault-Riche D, Sidhu SS
A Potent d-Protein Antagonist of VEGF-A is Nonimmunogenic, Metabolically Stable, and Longer-Circulating in Vivo.
Uppalapati M, Lee DJ, Mandal K, Li H, Miranda LP, Lowitz J, Kenney J, Adams JJ, Ault-Riché D, Kent SB, Sidhu SS
KIF14 negatively regulates Rap1a-Radil signaling during breast cancer progression.
Ahmed SM, Thériault BL, Uppalapati M, Chiu CW, Gallie BL, Sidhu SS, Angers S
5th Protein Engineering Canada Conference, 2024
Principal investigators: Woolley, Andrew G; Uppalapati, Maruti
Keywords: Allosteric Inhibitors; Computational Protein Design; Directed Evolution; Drug Design; Enzyme Engineering; Molecular Biology; Molecular Switches; Structural Biology
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.